March 06, 2012
Gilead Sciences Quad Study 102 Results Conference Call on Wednesday, March 7, 2012
Conference Call and Webcast to Follow
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mar. 6, 2012--
Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the Quad Study
102 results will be presented on a conference call on Wednesday, March
7, at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. The conference
call and slides will be accessible via the internet from the company’s
website.
To access the webcast link, log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
conference call to ensure adequate time for any software download that
may be required to listen to the webcast. Alternatively, please call
1-866-788-0541 (U.S.) or 1-857-350-1679 (international) and dial the
participant passcode 57882166 to access the call. Telephone replay will
be available approximately two hours after the call through 11:59 p.m.
Eastern Time, March 10, 2012. To access the replay, please call
1-888-286-8010 (U.S.) or 1-617-801-6888 (international) and dial the
participant passcode 14598403. The webcast will be archived on www.gilead.com
for 14 days following the call.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North America, Europe and Asia
Pacific.
For more information on Gilead Sciences, please visit www.gilead.com
or call the Gilead Public Affairs Department at 1-800-GILEAD-5
(1-800-445-3235).
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715
Investor
Relations
